PBMs are Misleading America
As Congress investigates the pharmacy benefit manager (PBM) problem, these middlemen corporations continue steering patients away from...
top of page
News
- Aug 16
Parties Agree — Lawmakers Need to Stop Drug Price Manipulation
The evidence against pharmacy benefit managers, or PBMs, has been piling up. Congress and multiple state legislatures have held hearings...
- Aug 8
Untangling The $500 Billion PBM Web: The Opaque Relationship Between Employers And Drug Middlemen
On the heels of the FTC’s investigation into pharmacy benefit managers for what many regard as anti-competitive business practices, legal...
- Aug 1
National Poll of Likely 2024 Voters Shows Strong Bipartisan Support for Specific PBM Reform Policies and Candidates Who Support Them
Likely Voters Want Policies to Require PBM Middlemen to Provide Value, Lower Out-of-Pocket Prescription Drug Costs Washington, DC – On...
- Jul 26
Drug middlemen say Pharma sets prices. Then why do middlemen have hundreds for the same drug?
Pharmacy middlemen known as pharmacy benefit managers deny claims that they’re responsible for the inflating cost of medicine. They say...
- Jul 23
PBM Accountability Project Members Host Important PBM Discussion on Capitol Hill
On Wednesday, July 9, the National Community Pharmacists Association (NCPA) and Coalition of State Rheumatology Organizations (CSRO) –...
- Jul 23
House hearing keeps pressure on PBM practices while Congress considers reforms
The hearing keeps attention on PBM reforms as Congress nears the period between elections in November and when newly elected officials...
- Jul 23
Medication middlemen face bipartisan criticism as Congress eyes industry reforms
Executives from three of the largest pharmacy benefit managers (PBMs) pushed back against bipartisan criticism during a House Oversight...
- Jul 10
PBM Accountability Project Statement on FTC Interim Report on PBMs
The Federal Trade Commission on July 9 issued its interim report on prescription drug middlemen known as pharmacy benefit managers or...
- Jul 9
F.T.C. Says Middlemen Appear to Be Driving Up Drug Prices
In a report, the regulator sharply criticized pharmacy benefit managers, a reversal from its longstanding hands-off approach to policing...
- Jul 9
Big Pharmacy-Benefit Managers Increase Drug Costs, FTC Says
Investigation finds firms, which are supposed to control spending, have overcharged for cancer drugs and taken other steps raising costs...
- Jul 9
FTC report finds PBMs profit at the expense of patients and independent pharmacies
In stark terms, the Federal Trade Commission found in a report released Tuesday that pharmacy benefit managers — the opaque middlemen in...
- Jun 25
Mail-Order Drugs Were Supposed to Keep Costs Down. It’s Doing the Opposite.
One employer was paying about $100 for a prescription for a generic antidepressant, though it could be bought elsewhere for about $12 A...
- Jun 21
New York Times Investigation Shows PBMs Rip Off Just About Everyone
The New York Times has published a detailed investigation into how middlemen pharmacy benefit managers (PBMs) drive up drug costs for...
- Jun 12
Watch: How pharmacy benefit managers influence drug pricing
This is Part 2 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. Watch here >
- Jun 12
Watch: The role of PBMs, patents, and public health in drug pricing
This is Part 1 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. Watch here >
- Jun 12
Bipartisan bill will bring prescription drug costs down (opinion)
Imagine going to the doctor and being told you have a life-threatening condition that can only be treated with a daily dose of...
- Jun 7
Rural pharmacies fill a health care gap in the US. Owners say it’s getting harder to stay open
Basin Pharmacy fills more than prescriptions in rural northern Wyoming. It’s also the key health care access point for the town of about...
- Jun 6
Burdensome step therapy requirements could delay care for cancer patients: analysis
Restrictive health plan policies are increasingly relying on step therapy for cancer drugs, recent analysis from consulting firm Avalere...
- May 30
Pharmacy Closures Spark Need for PBM Reform
Pharmacy benefit managers (PBMs) were first developed in 1958 as a prepayment plan for prescriptions. Today, PBMs function as middlemen...
- May 28
Senators See Possible Conflicts of Interest in Health Care Pricing Tools
A data analytics firm that helps insurers collect big fees while leaving some patients with unpaid bills has been summoned to explain its...
- May 22
PBM Accountability Project Statement on Senate Judiciary Committee Hearing
Yesterday, the Senate Judiciary Committee held a hearing, entitled “Ensuring Affordable & Accessible Medications: Examining Competition...
- May 16
PBM Accountability Project Statement on Energy and Commerce Committee Health Subcommittee Advancement of Healthcare Legislation
Today, the House Committee on Energy and Commerce Subcommittee on Health held a markup of 23 bills aimed at strengthening our healthcare...
- May 16
Delinking Medicare Prescription Costs from PBM Profits Protects Seniors
Our prescription drug pricing system in America is complex, confusing and often puts patients at a disadvantage. Insurance middlemen...
bottom of page